Drug Related Problems (DRPs) in Hospitalized patient with Eye Diseases: a Retrospective Cross-Sectional Study Over Two Years
Article Sidebar
Main Article Content
Page: 2311-2320
Abstract
Drug-related problems (DRPs) in ophthalmic inpatients may compromise the effectiveness and safety of therapy. This study aimed to identify the characteristics of DRPs among inpatients with eye diseases at Hospital X Tangerang during September 2022–August 2024. A retrospective cross-sectional design was applied, involving 178 patients who met the inclusion criteria. DRPs were identified using the Pharmaceutical Care Network Europe (PCNE) classification version 9.1 through review of prescriptions, clinical data, and medication records. Descriptive analysis were used to determine the DRP occurrence. Results showed that most patients were aged 18–60 years (71.9%), female (55.1%), without comorbidities (82.0%), and received an average of 5 medications during hospitalization. Four DRP cases (2.2%) were identified, consisting of one case of treatment effectiveness (P1.2) 25% and three cases of drug safety problems (P2.1) 75%. The main causes were contraindicated drug use despite guideline adherence (C1.2) 50%, inappropriate drug combinations (C1.4) 25%, and patient non-adherence (C7.1) 25%. The low DRP incidence was likely related to the short hospitalization duration and the predominance of topical therapy with minimal systemic exposure. These findings highlight the important role of clinical pharmacists in therapy monitoring to prevent DRPs in ophthalmic inpatients.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
PCNE. PCNE Classification for Drug-Related Problems V9.1. PCNE Assoc 2020;1:22–8.
Tasaka Y, Tanaka A, Yasunaga D, Asakawa T, Araki H, Tanaka M. Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan. J Pharm Heal Care Sci 2018;4:1–11. https://doi.org/10.1186/s40780-018-0125-z. DOI: https://doi.org/10.1186/s40780-018-0125-z
Jung-Poppe L, Nicolaus HF, Roggenhofer A, Altenbuchner A, Dormann H, Pfistermeister B, et al. Systematic Review of Risk Factors Assessed in Predictive Scoring Tools for Drug-Related Problems in Inpatients. J Clin Med 2022;11. https://doi.org/10.3390/jcm11175185. DOI: https://doi.org/10.3390/jcm11175185
Pramotesiri P, Putthipokin K, Ruangritchankul S. Drug Related Problems among Older Inpatients at a Tertiary Care Setting. J Clin Med 2024;13. https://doi.org/10.3390/jcm13061638. DOI: https://doi.org/10.3390/jcm13061638
Çakir A, Memiş H, Gün ZÜ, Biçakcioğlu M. Evaluation of Drug-Related Problems of Intensive Care Unit Patients by Clinical Pharmacists: A Retrospective Study. Turkish J Pharm Sci 2024;21:274–83. https://doi.org/10.4274/tjps.galenos.2023.44459. DOI: https://doi.org/10.4274/tjps.galenos.2023.44459
Ahmed NA, Fouad EA, El-Asheer OM, Ghanem ASM. Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability. Front Pharmacol 2024;15:1–14. https://doi.org/10.3389/fphar.2024.1391657. DOI: https://doi.org/10.3389/fphar.2024.1391657
Endalifer BL, Kassa MT, Ejigu YW, Ambaye AS. Polypharmacy, Drug–Drug Interactions, and Potentially Inappropriate Medications Among Older Adults: A cross-sectional study in Northeast Ethiopia. Front Public Heal 2025;13:1–8. https://doi.org/10.3389/fpubh.2025.1525079. DOI: https://doi.org/10.3389/fpubh.2025.1525079
Zhao L, Sun YJ, Pan ZQ. Topical Steroids and Antibiotics for Adult Blepharokeratoconjunctivitis (BKC): A Meta-Analysis of Randomized Clinical Trials. J Ophthalmol 2021;2021. https://doi.org/10.1155/2021/3467620. DOI: https://doi.org/10.1155/2021/3467620
Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: A pharmacokinetic perspective. Clin Ophthalmol 2016;10:2433–41. https://doi.org/10.2147/OPTH.S118409. DOI: https://doi.org/10.2147/OPTH.S118409
Samadi B, Lundstrom M, Zetterberg M, Nilsson I, Montan P, Behndig A, et al. Anti-inflammatory treatment after cataract surgery in Sweden: Changes in prescribing patterns from 2010 to 2017. BMJ Open Ophthalmol 2021;6:1–6. https://doi.org/10.1136/bmjophth-2020-000635. DOI: https://doi.org/10.1136/bmjophth-2020-000635
Ayalew MB, Tegegn HG, Abdela O. Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures. Bull Emerg Trauma 2019;7:339–46. https://doi.org/10.29252/beat-070401. DOI: https://doi.org/10.29252/beat-070401
Anggriani A, Utami P, Lisni I. Kajian Potensi Interaksi Obat Pada Pasien Glaukoma di Salah Satu Rumah Sakit di Bandung. J Sains Dan Kesehat 2016;1:226–35. DOI: https://doi.org/10.25026/jsk.v1i5.44
Husna I, Ramatillah DL, Anggraeni YD. Evaluasi Efek Samping Penggunaan Obat Tetes Mata Kortikosteroid Pada Pasien Pasca Operasi Di Instalasi Farmasi Rumah Sakit Mata Jakarta Eye Center Kedoya. Arch Pharm 2019;1:41.
Endalifer BL, Ayta YD, Tsigie AW, Wondmkun YT, Kassa MT, Amare GG, et al. Drug-therapy-related problems and pharmacist interventions in the medical ward in northeast Ethiopia: focus on types, acceptability, and impacts. Front Pharmacol 2025;16:1–12. https://doi.org/10.3389/fphar.2025.1558864. DOI: https://doi.org/10.3389/fphar.2025.1558864
Larasati N, Satibi S, Kristina SA, Lazuardi L. The Association between Drug-Related Problems and Length of Stay of Type 2 Diabetes Mellitus Patients. Malaysian J Med Sci 2024;31:162–73. https://doi.org/10.21315/mjms2024.31.4.13. DOI: https://doi.org/10.21315/mjms2024.31.4.13
Watanabe JH, McInnis T, Hirsch JD. Cost of Prescription Drug–Related Morbidity and Mortality. Ann Pharmacother 2018;52:829–37. https://doi.org/10.1177/1060028018765159. DOI: https://doi.org/10.1177/1060028018765159
Guo B, Lu P, Chen X, Zhang W, Chen R. Prevalence of dry eye disease in Mongolians at high altitude in China: The Henan eye study. Ophthalmic Epidemiol 2010;17:234–41. https://doi.org/10.3109/09286586.2010.498659. DOI: https://doi.org/10.3109/09286586.2010.498659
Keay L, Ren K, Nguyen H, Vajdic C, Odutola M, Gyawali R, et al. Risk factors common to leading eye health conditions and major non-communicable diseases: a rapid review and commentary. F1000Research 2022;11:1289. https://doi.org/10.12688/f1000research.123815.1. DOI: https://doi.org/10.12688/f1000research.123815.1
Usama F, Khokhar AR. Frequency of Diabetes Mellitus in Cataract Patients Visiting Civil Hospital, Karachi. Al-Shifa J Ophthalmol 2025;21:135–40.
American Diabetes Association. Microvascular complications and foot care: Standards of medical care in diabetes—2021. Diabetes Care 2021;44:S151–67. https://doi.org/10.2337/dc21-S011. DOI: https://doi.org/10.2337/dc21-S011
Asroruddin M, Nora RLD, Edwar L, Sjamsoe S, Susiyanti M. Various factors affecting the bacterial corneal ulcer healing: A 4-years study in referral tertiary eye hospital in Indonesia. Med J Indones 2015;24:150–5. https://doi.org/10.13181/mji.v24i3.1044. DOI: https://doi.org/10.13181/mji.v24i3.1044
Lu LJ, Chen X, Adelman RA. Clinical Etiologies, Microbial Spectrum, Antibiotic Susceptibilities, and Visual Acuity Outcomes of Acute Endophthalmitis. J Ocul Pharmacol Ther 2020;36:534–9. https://doi.org/10.1089/jop.2018.0074. DOI: https://doi.org/10.1089/jop.2018.0074
Mahabadi N, Gurnani B, Czyz CN. Bacterial Endophthalmitis. StatPearls 2024. https://doi.org/10.1007/s11908-009-0042-2. DOI: https://doi.org/10.1007/s11908-009-0042-2
Abdullah M, Khan MS, Latif S, Waqas HM, Khan MA, Sharjeel M. Comparison of The Efficacy of Starting Antibiotic Medications with Debridement of Ulcer Versus Antibiotics Alone in Cases of Bacterial Corneal Ulcer - A Randomized Control Trial 2025.
Ministry of Health Malaysia. National Antimicrobial Guideline. Natl Antimicrob Guidel 2012:6–7.
Permenkes RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 28 Tahun 2021 tentang Pedoman Penggunaan Antibiotik. 2021.
Haddad J El, Sabbakh N Al, Macaron MM, Shaaban H, Bourdakos NE, Shi A, et al. NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis. Am J Ophthalmol 2024;260:1–13. https://doi.org/10.1016/j.ajo.2023.09.027. DOI: https://doi.org/10.1016/j.ajo.2023.09.027
Holland EJ, Fingeret M, Mah FS. Use of Topical Steroids in Conjunctivitis: A Review of the Evidence. Cornea 2019;38:1062–7. https://doi.org/10.1097/ICO.0000000000001982. DOI: https://doi.org/10.1097/ICO.0000000000001982
Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: Proceedings of the ocean group meeting. Ocul Surf 2013;11:246–58. https://doi.org/10.1016/j.jtos.2013.07.003. DOI: https://doi.org/10.1016/j.jtos.2013.07.003
Al-Azayzih A, Kanaan RJ, Altawalbeh SM. Assessment of Drug-Related Problems and Health-Related Quality of Life Domains in Elderly Patients with Type 2 Diabetes Mellitus. Ther Clin Risk Manag 2023;19:913–28. https://doi.org/10.2147/TCRM.S434235. DOI: https://doi.org/10.2147/TCRM.S434235
Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, et al. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci Rep 2021;11:1–11. https://doi.org/10.1038/s41598-020-80560-2. DOI: https://doi.org/10.1038/s41598-020-80560-2
Kurtov M, Kilić P, Ikić L, Kurtov K, Dorčić G, Vodanović M, et al. Ciprofloxacin-Induced Anaphylactic Reaction Followed by Negative Provocation Test in Response to Levofloxacin: A Case Report. Med 2023;59:10–5. https://doi.org/10.3390/medicina59101784. DOI: https://doi.org/10.3390/medicina59101784
Jain SP, Jain PA. Bullous, fixed drug eruption to ciprofloxacin: A case report. J Clin Diagnostic Res 2013;7:744–5. https://doi.org/10.7860/JCDR/2013/4757.2901. DOI: https://doi.org/10.7860/JCDR/2013/4757.2901
Hendera; Suryana BP. Gastrointestinal Tolerability of Diclofenac Sodium and Meloxicam in Osteoarthritis Patient. Folia Medica Indones 2014;51:35–9.
Dalugama C, Pathirage M, Kularatne SAM. Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: A case report. J Med Case Rep 2018;12:1–5. https://doi.org/10.1186/s13256-018-1685-0. DOI: https://doi.org/10.1186/s13256-018-1685-0
Olagbemide OJ, Omosanya OE, Ayodapo AO, Agboola SM, Adeagbo AO, Olukokun TA. Family support and medication adherence among adult type 2 diabetes: Any meeting point? Ann Afr Med 2021;20:282–7. https://doi.org/10.4103/aam.aam_62_20. DOI: https://doi.org/10.4103/aam.aam_62_20
Horii T, Momo K, Yasu T, Kabeya Y, Atsuda K. Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan. PLoS One 2019;14:1–12. https://doi.org/10.1371/journal.pone.0223431. DOI: https://doi.org/10.1371/journal.pone.0223431
Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, et al. Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care 2015;38:604–9. https://doi.org/10.2337/dc14-2098. DOI: https://doi.org/10.2337/dc14-2098
Dubald M, Bourgeois S, Andrieu V, Fessi H. Ophthalmic drug delivery systems for antibiotherapy- A review. Pharmaceutics 2018;10. https://doi.org/10.3390/pharmaceutics10010010. DOI: https://doi.org/10.3390/pharmaceutics10010010
del Amo EM. Topical ophthalmic administration: Can a drug instilled onto the ocular surface exert an effect at the back of the eye? Front Drug Deliv 2022;2. https://doi.org/10.3389/fddev.2022.954771. DOI: https://doi.org/10.3389/fddev.2022.954771
Huiskes VJB, van den Ende CHM, Kruijtbosch M, Ensing HT, Meijs M, Meijs VMM, et al. Effectiveness of medication review on the number of drug-related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial. Br J Clin Pharmacol 2020;86:50–61. https://doi.org/10.1111/bcp.14125. DOI: https://doi.org/10.1111/bcp.14125
Setiawati MK, Yasin NM, Pramantara IDP. Pengaruh Intervensi Apoteker terhadap Tingkat Bahaya Drug-Related Problems pada Pasien Geriatrik Rawat Inap. J Manaj DAN PELAYANAN Farm (Journal Manag Pharm Pract 2021;11:201. https://doi.org/10.22146/jmpf.66776. DOI: https://doi.org/10.22146/jmpf.66776
Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and drug-related problems among coronary heart disease inpatients: A pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J 2018;18:e81–7. https://doi.org/10.18295/squmj.2018.18.01.013. DOI: https://doi.org/10.18295/squmj.2018.18.01.013
Albayrak A, Özbalcı D. Determination of drug-related problems in the hematology service: a prospective interventional study. BMC Cancer 2024;24:1–8. https://doi.org/10.1186/s12885-024-12291-w. DOI: https://doi.org/10.1186/s12885-024-12291-w